The chief executive of El Jannah says the cult charcoal chicken chain expects revenues of up to $300 million this financial year and has ambitions to nearly triple the number of its stores by 2027.

With the introduction of emerging therapies like obefazimod, MORF-057, tulisokibart, and others, the IBD market is expected to grow significantly. • In January 2025, Eli Lilly & Company announced that ...

At WEF, China’s dominance came under the microscope, with supply chain issues at the front and centre of concerns. Take, for example, electric vehicles (EVs). Overall EV sales globally have ...

RAHWAY, N.J. - Merck (NYSE:MRK), a global healthcare leader, has unveiled long-term efficacy and safety data for tulisokibart, an investigational treatment for inflammatory bowel... ByInvesting ...

Kevin O'Marah, the chief research officer and co-founder of Zero100, a community research platform working towards zero carbon, sheds more light on how supply chains are likely to be impacted by ...

Reimagining chain mail 3D architected materials that adapt and protect Date: January 21, 2025 Source: California Institute of Technology Summary: Experiments have yielded a fascinating new type of ...

1 Department of Immunology, Center of Immunomolecular Engineering, Innovation & Practice Base for Graduate Students Education, Zunyi Medical University, Zunyi, China 2 Department of Laboratory, The ...